The EMA has posted the press release with details of the CVMP's meeting of 5 – 7 November 2019 (Link). General news relating to regulatory affairs included MUMS guidance under the new veterinary medicines regulation (NVR), batch safety testing for vaccines and eSubmissions. Outside the CVMP plenary, the EMA has also published updates on MAA validation, alternatives to antimicrobials, regulatory science and the Agency's monthly activity.
The Committee started an Article 35 referral procedure for VMPs containing tiamulin hydrogen fumarate for pigs presented as premix for medicated feeding stuff and oral powder for in-feed use, due to concerns over efficacy against Brachyspira hyodysenteriae.
The Committee adopted a concept paper for the revision of scientific guidelines on MUMS/limited markets for VMPs, which takes into account the new provisions concerning limited markets in the NVR. This concept paper will be published for a period of public consultation in the coming weeks.
The Committee adopted the draft guideline VICH GL59 on harmonisation of criteria to waive laboratory animal batch safety testing for vaccines for veterinary use (Link).
A new version of the eSubmission Gateway XML delivery file user interface is now available, which leads to the abolishment of the need for the Formatted Table Template as a part of the submission cover letter, with effect from 1 January 2020 (Link).
Validation checklists for initial MA applications for veterinary pharmaceutical (Link) and immunological (Link) products are now available, providing applicants with the same checklists as used by assessors during validation.
The CVMP draft reflection paper on ‘Promoting the authorisation of alternatives to antimicrobials in the EU’ has now been published for public consultation (Link).
The EMA is holding a multi-stakeholder workshop on its Regulatory Science to 2025 strategy, on 5 – 6 December, which will be by invitation only. However, the event will be broadcast live on the EMA website, for any interested parties and a recording of the event will be available after the event (Link).
Aug – Sep monthly report on application procedures, guidelines and related documents for veterinary medicines now published (Link). This includes on the final pages a summary of the current status of 2019 guidelines and working documents.
Unparalleled Expertise for EU Centralised Procedures
Cyton has a strong collaborative working relationship with Dr. Anja Holm of CVPC, former chair of the CVMP.
As well as providing unique insights into our clients' projects, our collaboration with Dr. Holm also includes regulatory training courses. Follow the links below for more information.
- Central VetPharma website
- Training event: Innovative VMPs
Cyton Germany is now open for business!
Providing all the services available from Cyton UK, the new office ensures business continuity, post Brexit and beyond, for Cyton and our clients.
Clinical Expertise for the
Development and Registration
of your Veterinary Medicines
To find out more about how VRM
is working with Cyton to provide
a complete clinical service, please
visit the website: